Thor Medical ASA (FRA:8NN)
Germany · Delayed Price · Currency is EUR 0.3415
+0.0090 (2.71%)
Last updated: Nov 27, 2025, 8:02 AM CET
Thor Medical ASA Company Description
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway.
It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium.
The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Thor Medical ASA
| Country | Norway |
| Founded | 2009 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 9 |
| CEO | Jasper Kurth |
Contact Details
Address: Drammensveien 167 Oslo, 0277 Norway | |
| Phone | 47 97 41 40 00 |
| Website | thormedical.no |
Stock Details
| Ticker Symbol | 8NN |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jasper Kurth | Chief Executive Officer |
| Brede Ellingsæter | Chief Financial Officer |
| Brede Ellingsæter | Chief Operating Officer |